Parents Question Treatment After Daughter's Death: "Remarkable Events" in Case Revealed

The tragic death of 10-year-old Tilda Schön in 2019 continues to cast a long shadow, as her parents, Jerry Schön and Tilda's mother, are now demanding answers regarding her medical treatment. Tilda, who lived with a congenital heart defect, was reportedly on medication that saw its dosage quadrupled in the months preceding her death. Her parents never fully understood the reason for this significant increase and are now seeking clarity, especially after a local radio investigation brought attention to a pediatrician at Ryhov County Hospital in Jönköping who had allegedly misdiagnosed numerous children with congenital heart defects.

“

To know would mean everything to me

Initially, an external review conducted by Professor Jan Sunnegårdh, a pediatric cardiologist, concluded in November that no errors were made in Tilda's treatment and that her death was most likely due to a cardiac arrhythmia, a natural consequence of her illness. Simon Rundquist, the head of the pediatric clinic, conveyed this finding to the parents, stating there were "no signs of any incorrect treatment that caused the child's death." However, this conclusion did not sit well with Jerry Schön, who harbored lingering doubts about the treatment's normalcy.

“

There are no signs of any incorrect treatment that caused the child's death. And that is clear

Dagens Nyheter can now reveal that a discrepancy report was filed concerning Tilda's case last autumn. This report, commissioned by Rundquist and written by a doctor at the clinic, details the course of events. According to this report, Tilda experienced anxiety, restlessness, and panic attacks after her heart medication, enalapril, was quadrupled. Her parents contacted the hospital, described the symptoms, and were subsequently able to lower the dose. The doctor then instructed them to increase the dose again, leading to similar adverse effects, including sleep difficulties and loss of appetite, prompting another reduction in dosage. It remains unclear if a further increase was initiated before Tilda's death shortly thereafter. The Ryhov document describes "a series of remarkable events" related to her care, raising serious questions about the handling of her case and the initial conclusions drawn.

“

We had fun as usual, she was so happy